Latency in Pulmonary Tuberculosis

NCT01154959 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

120

Enrollment

OTHER_GOV

Sponsor class

Conditions

Pulmonary Tuberculosis

Interventions

DRUG: Moxifloxacin, Isoniazid, Rifampicin Pyrazinamide, Ethambutol

Sponsor

Tuberculosis Research Centre, India

Collaborators

[object Object]